FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmacology and represents the use of water-soluble hybrid macromolecular compounds: O-(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyl)-(1→6)-α-D-glucan, polyethylene glycol bis-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate as agents improving survival rate in wound shock.
EFFECT: invention provides the extended range of products applied in therapy for wound shock.
4 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
ERYTHROPROTECTIVE AGENT FOR PHENYLHYDRAZINE POISONING | 2011 |
|
RU2471488C1 |
AGENTS EHXIBITING HAEMORHEOLOGIC ACTIVITY | 2010 |
|
RU2425683C1 |
AGENT EHXIBITING HAEMORHEOLOGIC ACTIVITY | 2011 |
|
RU2473348C1 |
AGENT IMPROVING RHEOLOGICAL PROPERTIES OF BLOOD | 2013 |
|
RU2546297C1 |
MEANS FOR CEREBRAL BLOOD FLOW INCREASE | 2016 |
|
RU2655810C2 |
HEMORHEOLOGICAL AND ANTI-THROMBOSIS AGENT | 2003 |
|
RU2242221C1 |
AGENT POSSESSING NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2701739C1 |
OSMOTIC DIURETIC POSSESSING ANTITOXIC ACTIVITY IN CASE OF ALIPHATIC ALCOHOL POISONING | 2007 |
|
RU2354390C2 |
REMEDY HAVING ANTIAGGREGANT ACTIVITY, ACTIVITY DECREASING BLOOD HYPERVISCOSITY AND ANTITHROMBOGENIC ACTIVITY | 2008 |
|
RU2368376C1 |
DRUG DECREASING ERYTHROCYTE AGGREGATION | 1996 |
|
RU2123848C1 |
Authors
Dates
2013-01-10—Published
2011-12-22—Filed